IFNA1 and COVID-19: Similarly, inborn errors of innate antiviral mechanisms and IFN autoantibodies are associated with severe coronavirus disease 2019 (COVID-19)47–51, assumed to be explained by greater viral loads driving increased inflammatory disease.